MedTrace Logo

Use of Probiotics to Prevent Influenza

NCT01720329 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1440

Last updated 2018-10-26

No results posted yet for this study

Summary

The goal of this study is to assess the feasibility of randomizing residents of long-term care facilities to either probiotics or placebo to assess whether probiotics can reduce influenza and other viral laboratory confirmed respiratory infection.

Conditions

Interventions

DIETARY_SUPPLEMENT

Probiotics

Active comparator Arm. XXmls of XXX supplemented with XX of L. rhamnosus GG on a daily basis for six months

OTHER

probiotic placebo

Placebo comparator arm -Participants randomized to placebo will receive XXmls of XXX G on a daily basis for 6 months.

Sponsors & Collaborators

Principal Investigators

  • Mark Loeb, MD · McMaster University, Hamilton, ON, Canada

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2017-08-31
Completion
2017-10-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01720329 on ClinicalTrials.gov